Performance of CLBT Cellebrite DI | 120.8% in 12m
Compare CLBT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Cellebrite DI with its related Sector/Index XLK
![Compare Cellebrite DI with its related Sector/Index XLK](https://www.valueray.com/images/chart/CLBT.NASDAQ_perf.png)
Performance Duell CLBT vs XLK
TimeFrame | CLBT | XLK |
---|---|---|
1 Week | -4.22% | -7.45% |
1 Month | 31.7% | 1.66% |
3 Months | 54.9% | -5.03% |
6 Months | 41.5% | -1.25% |
12 Months | 120.8% | 18.32% |
YTD | 93.8% | 9.16% |
Rel. Perf. 1m | 2.33 | |
Rel. Perf. 3m | 3.92 | |
Rel. Perf. 6m | 3.55 | |
Rel. Perf. 12m | 3.55 | |
Spearman 1m | 0.74 | -0.03 |
Spearman 3m | 0.88 | -0.56 |
Is Cellebrite DI a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Cellebrite DI (NASDAQ:CLBT) is currently (September 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.60 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLBT as of September 2024 is 17.93. This means that CLBT is currently overvalued and has a potential downside of 9.73% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLBT as of September 2024 is 17.93. This means that CLBT is currently overvalued and has a potential downside of 9.73% (Sold with Premium).
Is CLBT a buy, sell or hold?
- Strong Buy: 6
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: CLBT is performing better - Values below 0%: CLBT is underperforming
Compare CLBT with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.08% | 28.18% | 34.79% | 98.63% |
US NASDAQ 100 | QQQ | 1.57% | 29.59% | 38.92% | 100.96% |
US Dow Jones Industrial 30 | DIA | -1.40% | 27.87% | 36.17% | 102.31% |
German DAX 40 | DBXD | -0.98% | 26.27% | 38.64% | 106.21% |
UK FTSE 100 | ISFU | -1.97% | 25.40% | 29.15% | 102.65% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.54% | 33.98% | 47.74% | 131.72% |
Hongkong Hang Seng | HSI | -2.00% | 26.90% | 40.96% | 126.65% |
Japan Nikkei 225 | EXX7 | 2.90% | 25.99% | 51.60% | 114.95% |
India NIFTY 50 | INDA | -2.12% | 29.06% | 33.03% | 96.50% |
Brasil Bovespa | EWZ | -2.51% | 24.79% | 49.98% | 120.57% |
CLBT Cellebrite DI vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.15% | 31.08% | 34.10% | 96.29% |
Consumer Discretionary | XLY | -1.70% | 26.28% | 39.48% | 114.72% |
Consumer Staples | XLP | -4.80% | 25.60% | 29.65% | 102.66% |
Energy | XLE | 1.55% | 32.79% | 41.15% | 122.95% |
Financial | XLF | -1.05% | 24.95% | 31.57% | 90.07% |
Health Care | XLV | -2.15% | 27.30% | 35.24% | 103.16% |
Industrial | XLI | 0.02% | 28.52% | 37.26% | 99.74% |
Materials | XLB | 0.44% | 30.08% | 39.37% | 109.16% |
Real Estate | XLRE | -4.40% | 26.66% | 29.70% | 97.44% |
Technology | XLK | 3.23% | 30.01% | 42.72% | 102.49% |
Utilities | XLU | -3.72% | 27.50% | 19.35% | 97.05% |
Aerospace & Defense | XAR | 0.99% | 27.67% | 37.00% | 94.47% |
Biotech | XBI | 0.46% | 29.47% | 44.95% | 98.20% |
Homebuilder | XHB | 0.18% | 28.25% | 33.63% | 83.21% |
Retail | XRT | 0.76% | 32.18% | 44.72% | 102.16% |
Does Cellebrite DI outperform its market, is CLBT a Sector Leader?
Yes, over the last 12 months Cellebrite DI (CLBT) made 120.81%, while its related Sector, the Technology Sector SPDR Fund (XLK) made 18.32%.
Over the last 3 months CLBT made 54.88%, while XLK made -5.03%.
Yes, over the last 12 months Cellebrite DI (CLBT) made 120.81%, while its related Sector, the Technology Sector SPDR Fund (XLK) made 18.32%.
Over the last 3 months CLBT made 54.88%, while XLK made -5.03%.
Period | CLBT | XLK | S&P 500 |
---|---|---|---|
1 Month | 31.67% | 1.66% | 3.49% |
3 Months | 54.88% | -5.03% | 1.39% |
12 Months | 120.81% | 18.32% | 22.18% |